Scientific article
English

Imeglimin - A New Oral Anti-Diabetic that Targets the Three Key Defects of type 2 Diabetes

Published inJournal of diabetes & metabolism, vol. 2, no. 4
Publication date2011
Citation (ISO format)
FOUQUERAY, Pascale et al. Imeglimin - A New Oral Anti-Diabetic that Targets the Three Key Defects of type 2 Diabetes. In: Journal of diabetes & metabolism, 2011, vol. 2, n° 4. doi: 10.4172/2155-6156.1000126
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN2155-6156
944views
1downloads

Technical informations

Creation26/02/2015 15:59:00
First validation26/02/2015 15:59:00
Update time14/03/2023 22:55:56
Status update14/03/2023 22:55:56
Last indexation30/10/2024 23:08:13
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack